Is the patient-perceived impact of psoriatic arthritis a global concept? An international study in 13 Arab countries (TACTIC study).

Autor: Ziadé N; Saint-Joseph University, Hotel-Dieu de France Hospital, Beirut, Lebanon. nellziade@yahoo.fr., Abbas N; Saint-Joseph University, Hotel-Dieu de France Hospital, Beirut, Lebanon., Hmamouchi I; Laboratory of Clinical Research and Epidemiology, Faculty of Medicine, Mohammed V University, Rabat, Morocco.; Health Sciences College, International University of Rabat (UIR), Rabat, Morocco., El Kibbi L; Division of Rheumatology, Department of Internal Medicine, Specialized Medical Centre, Riyadh, Saudi Arabia., Maroof A; University of Kurdistan-Hewler (UKH) School of Medicine; and Rizgary Hospital Erbil, Erbil, Iraq., Elzorkany B; Rheumatology Department, Cairo University, Giza, Egypt., Abdulateef N; Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq., Adnan A; Baghdad Teaching Hospital, Baghdad Medical City, Baghdad, Iraq., Ihsan Awadh N; Baghdad Teaching Hospital, Baghdad Medical City, Baghdad, Iraq., Gorial FI; Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq., Alchama N; Rheumatology Department, Ibn Al-Nafees Hospital, Damascus, Syria., Haouichat C; Rheumatology Department, Djilali Bounaama University Hospital, Khemis Miliana, Douera, Algiers, Algeria.; Faculty of Medicine El Mahdi Si Ahmed., Blida, Algeria., Alnaimat F; Division of Rheumatology, Department of Medicine, The University of Jordan, Amman, Jordan., Hannawi S; Rheumatology Department, Emirates Health Services, Ministry of Health and Prevention, Dubai, UAE., Atawnah S; Al-Ahli Hospital, Al-Quds University, Hebron, Palestine., Halabi H; Section of Rheumatology, Department of Internal Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia., Al Mashaleh M; Rheumatology Division of Internal Medicine, King Hussein Medical Centre, Royal Medical Services, Jordan Armed Forces, Amman, Jordan., Aljazwi L; Tripoli Central Hospital, Tripoli, Libya., Abogamal A; Al-Azhar Faculty of Medicine, Dr Sulaiman Al Habib Hospital, Dubai, UAE., Ayoub L; Rheumatology Unit, Department of Internal Medicine, Tripoli Central Hospital, Tripoli, Libya.; Faculty of Medicine, University of Tripoli, Tripoli, Libya., Bouajina E; Farhat Hached Hospital of Sousse, Sousse, Tunisia., Bahiri R; El Ayachi Hospital, Medical University Hospital, Rabat, Morocco., Saad S; Assiut Medical School of Egypt, King Hamad University Hospital Bahrain, Al Sayh, Bahrain., Sabkar M; King Hamad University Hospital, Al Sayh, Bahrain., Aouad K; Saint George Hospital University Medical Centre, Saint George University of Beirut, Beirut, Lebanon., Gossec L; INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France.; Rheumatology Department, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Jazyk: angličtina
Zdroj: Rheumatology international [Rheumatol Int] 2024 May; Vol. 44 (5), pp. 885-899. Date of Electronic Publication: 2024 Mar 18.
DOI: 10.1007/s00296-024-05552-1
Abstrakt: The Psoriatic Arthritis Impact of Disease (PsAID-12) questionnaire, a recommended measure of patient-reported impact for psoriatic arthritis (PsA), was initially developed in Europe and may lack universal validity. Recognizing the need for a culturally appropriate tool for Arab patients, this study aimed to TranslAte, CulTurally adapt, and validate the PsAID in ArabIC (TACTIC). The PsAID-12 was translated into Arabic using a rigorous process of double translation, back-translation, and cognitive debriefing. The Arabic version was then validated through a study conducted in 13 Arab countries in 2022. Participants were consecutive literate adult patients diagnosed with PsA and fulfilling the CASPAR criteria. Collected data included PsAID-12, disease activity, and legacy patient-reported outcomes. Psychometric properties, such as internal consistency, construct validity, and test-retest reliability, were examined. Factors associated with high PsAID-12 total scores (> 4) were explored using multivariable binary logistic regression. A culturally adapted Arabic PsAID-12 questionnaire was achieved with minor rephrasing. The validation study included 554 patients from 13 countries (mean age 45 years, 59% females), with a mean PsAID score of 3.86 (SD 2.33). The Arabic PsAID-12 demonstrated excellent internal consistency (Cronbach's α = 0.95), and correlations with other measures ranged from 0.63 to 0.78. Test-retest reliability (N = 138 patients) was substantial (intraclass correlation coefficient, ICC 0.90 [0.86-0.93]; Cohen's kappa 0.80). Factors associated with a high PsAID score were disability (odds ratio, OR 3.15 [2.03-4.89]), depression (OR 1.56 [1.35-1.81]), widespread pain (OR 1.31 [1.12-1.53]), and disease activity (OR 1.29 [1.13-1.47]). Pain and fatigue were identified as the most impactful PsAID-12 domains for PsA patients. The Arabic PsAID is a valid and reliable measure that reflects the priorities of patients with PsA. PsAID scores correlated with disease activity and legacy outcome measures, as expected, indicating PsAID is a consistent measure of PsA impact across cultures. These findings highlight the potential of the Arabic PsAID in improving the care provided to Arabic-speaking patients worldwide.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: